Article
Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.
Arteriosclerosis, thrombosis, and vascular biology - 1 Jul 2025
Aubdool Aisah A, Moyes Amie J, Perez-Ternero Cristina, Baliga Reshma S, Sanghera Jaspinder Singh, Syed M Taaha, Jaigirdar Kareemah, Panesar Anmolpreet K, Tsui Janice C, Li Yanming, Vasquez Hernan G, Shen Ying H, LeMaire Scott A, Raffort Juliette, Mallat Ziad, Lu Hong S, Daugherty Alan, Hobbs Adrian J
Abstract excerpt
BACKGROUND: Thoracic (TAA) and abdominal (AAA) aortic aneurysm are life-threatening diseases characterized by dilation, inflammation, and structural weakness; development of pharmacological therapies is desperately needed. CNP (C-type natriuretic peptide) plays a key role in vascular homeostasis, mediating vasodilator, anti-inflammatory, and antiatherogenic actions. Since such processes drive AA, we determined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
